Thursday, August 20, 2015

Anthem To Cover Libido Drug So Women Can Get Their Sex On

Big Pharma wins again with yet another recreational drug that has zero health benefits. There's a new pink pill to treat women who claim their libido is too low not unlike the companion drugs offered to men to treat erectile dysfunction. Without insurance, a patient would have to shell out $400 a month to pay for the drug, Addyi. No worries though. Anthem, an insurance company I left because I could no longer afford the outrageous premiums, will cover the new drug. About 70% of insurance plans cover similar drugs like Ciallis and Viagra for men, which I think is equally appalling. Most people who truly have problems down there is because of some other drug Big Pharma has convinced them they need for healthy living, which is not the case about 90% of the time. The maker of Addyi says there are no side effects unless you're under the influence of alcohol, in which case the drug can cause a sudden drop in blood pressure or fainting. Then people wonder why the cost of obtaining affordable health insurance in this country is so elusive.

7 comments:

Anonymous said...

I also was forced to leave Anthem because their premium increases made health insurance unaffordable for the self employed. My policy, which I had enjoyed for ten years, skyrocketed until I was paying $900 a month counting deductibles and copays and premiums and such out of my pocket. This was many years ago. Now there are a lot of people who pay these amounts. But in a matter of a few short years my out of pocket tripled with Anthem, as they made a conscious decision to price out individual self employed type policies in favor of group policies. They left me in a terrible position for a while until I was able to figure out how to replace coverage, and by then I had a preexisting condition. It was just a terrible time for my family. And Anthem could not have been colder or ruder. They were awful, and it almost cost me my home. I couldn’t believe the heartlessness. Later, of course, then CEO Angela Braly would begin dropping breast cancer patients because they cost her too much, and we would see yet another instance of what they called good business. They can all burn in a fiery pit. That’s my opinion of Anthem and their management.

Gary R. Welsh said...

Not to mention that Anthem's beginning was a total fraud on the public. The old Blue Cross-Blue Shield companies were established as mutual, nonprofit insurance companies to provide affordable health care. The people at the top of the organization took it private and all of them immediately became multi-millionaires. This repeated itself across the country and you wound up with one giant company that totally bastardized the original mission it had all of those years it enjoyed nonprofit status. Virtually every member of our state legislature and congressional delegation will prostitute for this company on demand.

Anonymous said...

Why is a drug that is 10% effective allowed on the open market?

Gary R. Welsh said...

Good question. You would think it was some miracle drug the way it's being covered by the mainstream news media this week.

Anonymous said...

I realize it is not your point, but this drug is _completely_ unlike the "companion drugs offered to men", is so ineffective & has such pronounced side effects that it is only being market to physicians -- unlike the men's ED pills that are marketed relentlessly through every medium, to everybody.
The solution, imho, is for insurance carriers to end coverage of Viagra, Cialis and all ED drugs, devices and procedures, and refuse to cover Addyi as well.
Lobbying by PHARMA is what got this drug covered.

Gary R. Welsh said...

They don't need to advertise when Good Morning America, The Today Show, Fox, CNN, et al. run effusive, puff stories promoting the drug the way they've collectively done this past week alone. What's that all about?

Sir Hailstone said...

Laughing all the way to the stock market. Somebody is coming out big here - the pharma company that produces this female libido drug was just bought by a larger competitor today.

Yeah. As the commenter on WBBM-AM said during the Crain's Chicago Business hour - "Wow. That didn't take long"